Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels

Area of Science:

• Cardiovascular Medicine
• Genetics
• Metabolic Disorders

Background:

• Familial hypercholesterolemia (FH) is a genetic disorder causing high LDL-C levels.
• Lifelong high LDL-C in FH patients significantly increases premature cardiovascular disease (CVD) risk.
• Variability in CVD event rates among FH patients suggests other risk factors are involved.

Purpose of the Study:

• To review the CVD risk burden in the FH population.
• To examine traditional and emerging CVD risk predictors in FH.
• To provide an overview of CVD risk stratification tools for personalized FH treatment.

Main Methods:

• Literature review of studies on Familial hypercholesterolemia.
• Analysis of cardiovascular disease risk factors in FH patients.
• Evaluation of risk stratification tools for FH management.

Main Results:

• FH patients have a substantially elevated risk of premature CVD.
• Factors beyond LDL-C levels influence CVD risk in FH.
• Various tools can aid in stratifying CVD risk for personalized FH care.

Conclusions:

• Understanding additional CVD risk modifiers is crucial for FH management.
• Personalized risk stratification can optimize treatment strategies for FH patients.
• Further research into emerging risk predictors may improve CVD event prediction in FH.